Every result here is measured on recognised, held-out benchmarks and scored with the same production weights the platform serves — held-out scaffold splits for the property models, and genuinely blinded tests for binding. We show the strong results and, below, the limits that qualify them.
Our microsomal-stability model beats the public leaderboard.
On the official public test split, Gnosis V’s microsomal-stability model reaches Spearman 0.000 — above the published leaderboard reference — and ships with validated prediction intervals rather than a bare point estimate.
0.000
Spearman, official test split
0%
of test compounds in-domain
Public leaderboard 0.630
Vecentra model0.000
scale 0 to 1 · Spearman
Gnosis I · Fused binding
Physics-grade ranking, in minutes
On the public FEP+/JACS binding benchmark, the Fused ranking engine lands in the band between OpenFE and FEP+, the physics-based gold standard, while running in minutes per compound instead of the hours of simulation those methods need. And on a fully blinded oncology target, it self-corrects where a naive approach fails.
On par with physics, in minutes
Public FEP+/JACS set · Pearson correlation
FEP+ (physics, hours/ligand)0.000
Vecentra co-folding (minutes)0.000
OpenFE (physics, hours/ligand)0.000
scale 0 to 1 · Pearson r
These congeneric series are in-domain, so this is an optimistic upper bound, not a blinded test. The blinded result is shown alongside.
A naive co-fold ranked worse than random. Measuring which signal to trust against known actives recovered strong rank agreement, on compounds never seen.
Rank-only. Absolute potency is reported only when a per-target calibration gate passes.
Gnosis III · Systemic safety
Organ-toxicity discrimination
Production safety heads on the held-out test split. hERG cardiac-risk is the standout. AUROC is shown on a 0.5-to-1.0 scale, so the bar length is the honest distance above random.
hERG cardiac-risk0.000AUROC
high vs lown = 282
Ames mutagenicity0.000AUROC
n = 1,439
Cardiotoxicity flag0.000AUROC
n = 804
Gnosis V · ADMET (classification)
Metabolism, CNS and transport
CYP inhibition liability, blood-brain-barrier penetration and P-gp transport, each on its own held-out scaffold split. These are the inhibition heads; the separate CYP substrate heads are weaker and are not reported here.
CYP1A2 inhibition0.000AUROC
n = 7,400
CYP3A4 inhibition0.000AUROC
n = 7,272
CYP2C19 inhibition0.000AUROC
n = 7,486
CYP2C9 inhibition0.000AUROC
n = 7,190
Blood-brain barrier0.000AUROC
n = 389
P-gp substrate0.000AUROC
applicability-domain gatedn = 200
Gnosis V · ADMET (regression)
Physicochemical and PK properties
Correlation against measured values on held-out splits. Solubility roughly halves the error of a mean predictor. These are rank/triage reads, not calibrated points.
Aqueous solubility0.000Pearson r
MAE 0.90 vs 1.87 baselinen = 1,881
Caco-2 permeability0.000Pearson r
n = 178
Lipophilicity (logD)0.000Pearson r
n = 840
Volume of distribution0.000Pearson r
n = 217
See it run on a compound you choose.
The honest version: your molecule, every module, the limits stated as you have seen here.